Table 1.
Prevalence of dyslipidemia based on health status and for the general population in Africa, 2021.
| Authors | Year | Country | Region | Study participant | Study design | Sample size | Frequency | LDL-C in % |
|---|---|---|---|---|---|---|---|---|
| Kemal et al. (16) | 2020 | Ethiopia | East Africa | Patients on ART | Cross-sectional | 353 | 264 | 31.2 |
| Kiplagat et al. (32) | 2017 | Kenya | East Africa | Type-2 DM | Cross-sectional | 265 | 208 | Not reported |
| Abdu et al. (33) | 2020 | Ethiopia | East Africa | Patients with H. Pylori | Cross-sectional | 369 | 286 | 79.7 |
| Haile et al. (34) | 2020 | Ethiopia | East Africa | Diabetes patients | Cross-sectional | 248 | 169 | 28.6 |
| Bekele et al. (35) | 2017 | Ethiopia | East Africa | Diabetes patients | Cross-sectional | 224 | 150 | 43.8 |
| Sufa et al. (8) | 2019 | Ethiopia | East Africa | General population | Cross-sectional | 365 | 127 | 34.8 |
| Okpala et al. (30) | 2019 | Nigeria | West Africa | Lichen Planus patients | Cross-sectional | 90 | 15 | Not reported |
| Yusuf et al. (36) | 2015 | Nigeria | West Africa | Lichen Planus patients | Cross-sectional | 180 | 51 | Not reported |
| Fikremariam et al. (37) | 2018 | Ethiopia | East Africa | Diabetes patients | Cross-sectional | 112 | 94 | Not reported |
| Ditorguéna et al. (38) | 2019 | Togo | West Africa | General population | Cross-sectional | 746 | 450 | 0.7 |
| Amberbir et al. (39) | 2018 | Malawi | Central Africa | HIV patients | Cross-sectional | 554 | 86 | Not reported |
| Tilahun et al. (2) | 2021 | Kenya | East Africa | HIV patients | Cross-sectional | 564 | 265 | 26.6 |
| Ciccacci et al. (40) | 2021 | Mozambique | Southern Africa | DM and HTN patients | Cross-sectional | 885 | 410 | Not reported |
| Hamooya et al. (41) | 2021 | Zambia | Central Africa | HIV patients | Cross-sectional | 1,108 | 293 | Not reported |
| Gebreegziabiher et al. (17) | 2021 | Ethiopia | East Africa | General population | Cross-sectional | 370 | 204 | 49.5 |
| Doupa et al. (42) | 2014 | Senegal | West Africa | General population | Cross-sectional | 1,329 | 880 | 66.2 |
| Asiki et al. (43) | 2015 | Uganda | East Africa | General population | Cross-sectional | 7,809 | 5,567 | 5.2 |
| Tadewos et al. (44) | 2012 | Ethiopia | East Africa | HIV | Comparative | 113 | 67 | 48.7 |
| Ayoadea et al. (45) | 2020 | Nigeria | West Africa | HTN patients | Cross-sectional | 544 | 326 | 27.9 |
| Dave et al. (14) | 2016 | South Africa | Southern Africa | HIV | Comparative | 957 | 861 | 55.1 |
| Jamieson et al. (31) | 2017 | South Africa | Southern Africa | HIV | Cohort study | 10,690 | 595 | Not reported |
| Pitso et al. (46) | 2021 | South Africa | Southern Africa | Diabetes | Cross-sectional | 143 | 120 | 20.9 |
| Innes et al. (47) | 2016 | South Africa | Southern Africa | HIV | Longitudinal | 96 | 38 | 26 |
| Gebreyes et al. (13) | 2018 | Ethiopia | East Africa | General population | National survey | 9,788 | 509 | 14.1 |
*ART, anti-retroviral therapy and DM, diabetes mellitus.